Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens

Cancer Letters

Volumn 140, Issue 1-2, 1999, Pages 27-35

  Brueggemeier, Robert W ^a,b   Quinn, Anne L ^a   Parrett, Michelle L ^a   Joarder, Farahnaz S ^a   Harris, Randall E ^a,b   Robertson, Fredika M ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Aromatase; Breast cancer; Cyclooxygenase

Indexed keywords

AROMATASE; ISOENZYME; MESSENGER RNA; PROSTAGLANDIN SYNTHASE;

ADULT; ARTICLE; BREAST; BREAST TUMOR; CONTROLLED STUDY; ESTROGEN SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; REGRESSION ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AROMATASE; BREAST NEOPLASMS; CELL COUNT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION; ISOENZYMES; LINEAR MODELS; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0033011694     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00050-6     Document Type: Article

References (49)

1. Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Hinselwood M.M., Graham-Lorence S., Amarneh B., Ito Y., Fisher C.R., Michael M.D., Mendelson C.R., Bulun S. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr. Rev. 15:1994;342-355.
2. Simpson E.R., Mahendroo M.S., Means G.D., Kilgore M.W., Corbin C.J., Mendelson C.R. Tissue-specific promoters regulate aromatase cytochrome P450 expression. J. Steroid Biochem. Mol. Biol. 44:1993;321-330.
3. Kellis J.T., Vickery L.E. Purification and characterization of human placental aromatase cytochrome P-450. J. Biol. Chem. 262:1987;4413-4420.
4. James V.H.T., McNeill J.M., Lai L.C., Newton C.J., Braunsberg H., Ghilchik M., Reed M.J. Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies. Steroids. 50:1987;269-279.
5. Miller W.R., Mullen P., Sourdaine P., Watson C., Dixon J.M., Telford J. Regulation of aromatase activity within the breast. J. Steroid Biochem. Mol. Biol. 61:1997;193-202.
6. Reed M.J., Topping L., Coldham N.G., Purohit A., Ghilchik M.W., James V.H.T. Interleukin-1 and interleukin-6 in breast cyst fluid: their role in regulating aromatase activity in breast cancer cells. J. Steroid Biochem. Mol. Biol. 44:1993;589-596.
7. Reed M.J. The role of aromatase in breast tumors. Breast Cancer Res. Treat. 30:1994;7-17.
8. Bulum S.E., Price T.M., Mahendroo M.S., Aitken J., Simpson E.R. A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcriptase. J. Clin. Endocrinol. Metab. 77:1993;1622-1628.
9. Sanghera M.K., Simpson E.R., McPhaul M.J., Kozlowski G., Conley A.J., Lephart E.D. Immunocytochemical distribution of aromatase cytochrome P450 in the rat brain using peptide-generated polyclonal antibodies. Endocrinology. 129:1991;2834-2844.
10. Means G.D., Kilgore M.W., Mahendroo M.S., Mendelson C.R., Simpson E.R. Tissue-specific promoters regulate aromatase cytochrome P450 gene expression in human ovary and fetal tissues. Mol. Endocrinol. 5:1991;2005-2013.
11. McPhaul M.J., Herbst M.A., Matsumine H., Young M., Lephart E.D. Diverse mechanisms of control of aromatase gene expression. J. Steroid Biochem. Mol. Biol. 44:1993;341-346.
12. Zhao Y., Agarwal V., Mendelson C., Simpson E. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinol. 137:1996;5739-5742.
13. Zhou C., Zhou D., Esteban J., Murai J., Siiteri P.K., Wilczynski S., Chen S. Aromatase gene expression and its exon I usage in human breast tumors. J. Steroid Biochem. Mol. Biol. 59:1996;163-171.
14. Hughes R., Timmermans P., Schrey M.P. Regulation of arachidonic acid metabolism, aromatase activity, and growth in human breast cancer cells by interleukin-1β and phorbol ester. Int. J. Cancer. 67:1996;684-689.
15. Smith W.L., Garavito R.M., DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenase)-1 and -2. J. Biol. Chem. 271:1996;33157-33160.
16. Williams C.S., DuBois R.N. Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol. 270:1996;G393-G400.
17. Herschman H.R. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev. 13:1994;241-256.
18. O'Neill G.P., Ford-Hutchinson A.W. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Letts. 330:1993;156-160.
19. Wallace J.L. Prostaglandins, NSAIDs, and cytoprotection. Gastroenterol. Clin North Am. 21:1992;L631-L641.
20. Hershman H.R. Prostaglandin synthase 2. Biochem. Biophys. Acta. 1299:1996;125-140.
21. Wu K.K.J. Cyclooxygenase 2 induction: molecular mechanism and pathophysiologic roles. Lab. Clin. Med. 128:1996;242-245.
22. Seibert K., Zhang Y., Leahy K., Hauser S., Masferrer J., Perkins W., Lee L., Isakson P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA. 91:1994;12013-12017.
23. Vane J.R., Mitchell J.A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., Willoughbor D.A. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc. Natl. Acad. Sci. USA. 91:1994;2046-2050.
24. Bennett A., Charlier E.M., McDonald A.M., Simpson J.S., Stamford I.F., Zebro T. Prostaglandins and breast cancer. Lancet. 2:1977;624-626.
25. Bennett A. The production of prostanoids in human cancers and their implications for tumor progression. Prog. Lipid Res. 25:1986;539-542.
26. Rigas B., Goldman I.S., Levine L. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med. 122:1993;518-523.
27. Bennett A., Civier A., Hensby C.N., Meihuish P.B., Stamford I.F. Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues. Gut. 28:1987;315-318.
28. Jung T.T., Berlinger N.T., Juhn S.K. Prostaglandins in squamous cell carcinomas of the head and neck. Laryngoscope. 95:1985;212-307.
29. Narisawa T., Satoh M., Sano M., Takahasbi T. Inhibition of initiation and promotion of N-methylnitrosourea-induced colon carcinogenesis in rats by non-steroidal anti-inflammatory agent indomethacin. Carcinogenesis. 14:1993;1493-1497.
30. Reddy B.S., Rao C.V., Rivenson A., Kelloff G. Inhibitory effect of aspirin on azoxymethaneinduced colon carcinogenesis in F344 rats. Carcinogenesis. 14:1993;1493-1497.
31. McCormick D.L., Moon R.C. Inhibition of mammary carcinogenesis by flurbiprofen, a non-steroidal anti-inflammatory agent. Br. J. Cancer. 48:1983;859-861.
32. Fulton A.M. In vivo effects of indomethacin on the growth of murine mammary tumors. Cancer Res. 44:1984;2416-2420.
33. Carter C.A., Ip M.M., Ip C. A comparison of the effects of the prostaglandin synthesis inhibitors indomethacin and carprofen in 7,12-dimethylbenz(a)-anthracene-induced mammary tumorigenesis in rats fed different amounts of essential fatty acids. Carcinogenesis. 10:1989;1369-1374.
34. Reeves M.J., Newcomb P.A., Trentham-Dietz A., Storer B.E., Remington P.L. Non-steroidal anti-inflammatory drug use and protection against colorectal cancer in women. Cancer Epidemiol. Biomark. Prevent. 5:1996;955-960.
35. Giovannuci E., Egan K.M., Hunter D.J., Stampfer M.J., Colditz G.A., Willett W.C., Speitzer F.E. Aspirin use and the risk of colorectal cancer in women. N. Engl. J. Med. 333:1995;609-614.
36. Bennett A., Berstock D.A., Carroll M.A., Stamford I.F., Wilson A.L. Breast cancer, its recurrence, and patient survival in relation to tumor prostaglandins. Adv. Prostaglandin Thromboxane Leukotriene Res. 12:1983;299-302.
37. Bennett A., Berstock D.A., Raja B., Stamford I.F. Survival time after surgery is inversely related to the amounts of prostaglandins extracted from human breast cancers. Br. J. Pharmacol. 66:1979;451P.
38. Rolland P.H., Martin P.M., Jacquemeier J., Rolland A.M., Toga M.J. Prostaglandin in human breast cancer: evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J. Natl. Cancer Inst. 64:1980;1061-1070.
39. Fulton A.M., Roi L., Howard L., Russo J., Brooks S., Brennan M.J. Breast Cancer Res. Treat. 2:1982;331.
40. Fulton A.M., Ownby H.E., Frederick J., Brennan M.J. Prostaglandin in human breast cancer: evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. Invasion Metastasis. 6:1986;83-94.
41. Watson D.M.A., Kelly R.W., Hawkins R.A., Miller W.R. Prostaglandins in human mammary cancer. Br. J. Cancer. 49:1984;459-464.
42. Singhakowinta A., Potter H.G., Buroker T.R., Samal B., Brooks S.C., Vaitkevicius V.K. Estrogen receptor and natural course of breast cancer. Ann. Surg. 183:1976;84.
43. Harris R.E., Namboodiri K.K., Steilman S.D., Wynder E.L. Breast cancer and NSAID use: heterogeneity of effect in a case-control study. Preven. Med. 24:1995;119-120.
44. Harris R.E., Namboodiri K.K., Farrar W.B. Non-steroidal anti-inflammatory drugs and breast cancer. Epidemiology. 7:1996;203-205.
45. Harris R.E., Namboodiri K.K., Farrar W.B. Epidemiological study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncology Reports. 2:1995;591-592.
46. Lui X.H., Rose D.P. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines. Cancer Res. 56:1996;5125-5127.
47. Parrett M.L., Harris R.E., Joarder F.S., Ross M.S., Clausen K.P., Robertson F.M. Cycooxygenase-2 gene expression in human breast cancer. Int. J. Oncology. 10:1997;503-507.
48. Hwang S., Scollard D., Byrne J., Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J. Nat. Cancer Inst. 90:1998;455-460.
49. Subbbaramaiah K., Terlang N., Ramonetti J.T., Araki R., DeVito B., Weksler B.B., Dannenberg A.J. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res. 56:1996;4424-4429.